FMHR trader Jon Najarian has seen strong options activity in one of Carl Icahn's favorite stocks Talisman Energy.» Read More
Commercial Metals landed on the trader radar after the Fast Money pros spoke with billionaire investor Carl Icahn about his hostile $1.8 billion bid to buy the company.
The Fast Money traders with the play on CMC following Carl Ichan's comments regarding his attempted takeover bid of the company.
Billionaire investor Carl Icahn discusses why he has taken his takeover bid directly to CMC shareholders, and the difference between this bid and his takeover attempt of Clorox. Icahn also weighs in on a possible Navistar/Oshkosh merger, the presidential election, and the U.S. economy.
The Fast Money traders weigh in on the rally in shares of U.S. Steel, and Carl Icahn's offer to acquire Commercial Metals for $15 per share.
Seasonal uptick in steel stocks makes it worth looking at for December, Fast Money pros say.
Carl C. Icahn and William A. Ackman battled in multiple courts over a 2004 deal, though it involved a sum of money that might seem like small potatoes to them, the New York Times reports.
Billionaire investor Carl Icahn added to his position in truck maker Navistar International. Here's what moves the "Fast" traders are making.
Carl Icahn is famed for his prowess to spot opportunity. And on Monday he told Fast Money exclusively that RIM does not have his attention.
"Of course we like the deal," says Carl Icahn, of Icahn Enterprises, who owns a 6% stake in El Paso. "It's a win-win for both of them."
Mad Money's Cramer says investors can always fall back on high-yielding dividend stocks that pay you to wait, like Clorox. Discussing the future of the company, now that it turned down Carl Icahn's $80/share bid, with Donald Knauss, Clorox CEO.
Collin Gillis, BGC Partners technology analyst weighs in on RIMM's pop in trading this morning.
Debating whether Carl Icahn's bid for Clorox was a realistic deal, with the Fast Money traders.
CNBC's David Faber provides insight on why Carl Icahn withdrew his proxy fight at Clorox.
CNBC's Brad Goode has the story on the settlement agreement between Icahn and Lionsgate.
Billionaire investor Carl Icahn has decided to go after the Clorox board, reports CNBC's David Faber. And a look at the beating HP is taking today.
Volatility last week has left some scars, says Jim Iuorio, TJM Institutional Services. "People seem to be ready to tip toe back into the stock market," he says.
Clorox shares dropped again today as investors question whether Carl Icahn will manage to seal a deal with the company, with the Fast Money team.
Digging deep into the SEC filings to see what the billionaires are doing with their holdings. CNBC's Brian Sullivan has the details.
Billionaire investor Carl Ichan ups Forest Labs stake to 20 million from 5 million, with the Fast Money crew.
Forest Laboratories said it won backing from proxy advisory firm ISS for all 10 of its board nominees in a proxy battle with billionaire investor Carl Icahn.